Genome-editing patents belong to Broad Institute, board says

The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT. The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome-editing technology belong to the Broad Institute of Harvard and MIT, dealing a blow to the University of California’s efforts to overturn those patents.

Rare blood disease improves the defence against germs

Researchers of the HZI and of the University of Magdeburg find increased immune reaction associated with a rare bone marrow disease Patients afflicted by myeloproliferative neoplasia – a group of chronic malignant bone marrow diseases – bear a mutation in their haematopoietic stem cells. The mutation leads to the bone marrow producing too many blood cells, which thickens the blood.

Sydney chiropractor Hance Limboro fined $27,500 for cancer cure advertisements

The online advertisement proclaimed: “By having a regular visit to a chiropractor, people can rest assured that they are prevented from having cancer.” Sydney chiropractor Hance Limboroa is the first person in the country to be prosecuted by the Australian Health Practitioner Regulation Agency for misleading advertising, relating to a series of ads on a website called Cancer Cure Sydney.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

Can banking baby teeth treat diabetes?

When she was just 11 months old, Billie Sue Wozniak’s daughter Juno was diagnosed with type 1 diabetes, an autoimmune disease that affects 1.25 million people and approximately 200,000 children under age 20 in the United States. The disease had affected several members of Billie Sue’s family, including her uncle, who passed away at the age of 30. “My first thought was, ‘Her life is going to be short,'” the 38-year-old from Reno, Nevada recalled.

The Man. The Myth. The Moustache.

When John Stossel was diagnosed with lung cancer in April, he announced it in the most characteristic way possible: He dashed off a column from his hospital bed with a quickie economic analysis of why nurses don’t care when your out-of-date heart monitor beeps all night long. Stossel, 69, is now cancer-free and ready to move on to the next thing.

Jacqueline Kennedy to British lord she rejected: I love you like a brother

Jaqueline Kennedy Onassis, embracing her daughter, Caroline Kennedy, and her new husband, Greek shipping magnate Aristotle Onassis aboard the yacht, Christina, shortly after their wedding in Greece on October 21, 1968. Widowed first lady Jacqueline Kennedy had at least one serious alternative to marrying Greek shipping tycoon Aristotle Onassis in October 1968: a British lord and former ambassador to Washington who had been one of John F. Kennedy’s closest friends, according to the New York Times .

New study uncovers important links between glioblastoma and epileptic seizures

Detecting brain tumors at the earliest possible stage and eliminating them before seizures begin might be possible one day, according to research by scientists at Baylor College of Medicine and Texas Children’s Hospital. In the study, which is published in the journal Nature Neuroscience , the scientists report that the emergence of specific brain cells during brain tumor progression in a mouse model marked the onset of seizures and brain tumor invasion.

Biotech leaders blast Trump’s immigration order

More than 160 leaders of biotechnology companies signed a strong letter of opposition to President Trump’s travel ban, arguing the ”poorly conceived and implemented” action strikes at the heart of an industry that originated in America, has been dominated by American companies, and is at the cutting edge of medicine. The letter, published Tuesday by the journal Nature Biotechnology, reveals that scientists abroad are afraid to come to the United States and are canceling trips.

Quotient Clinical expands into USA through acquisition of SeaView…

Quotient Clinical , the early phase drug development services provider, today announces that it has acquired SeaView Research , expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.

Global Teleradiology Market: Trend Analysis and Forecast to 2022 – Research and Markets

Teleradiology is the ability to obtain radiological patient images such as, X-rays, MRI’s, and CT’s in one location and their transmission over a distance so that they can be viewed and interpreted for diagnostic or consultative purpose by a radiologist or physician. Teleradiology is a cost effective and time saving tool for analyzing and treating patients during critical emergency situations, as a result physicians and radiologists have started adopting Teleradiology services due to advanced information and communication tools.

Mission Bio Receives Investment from Life Science Angels

Mission Bio, Inc. announced today that it has secured funding from U.S. top ranked angel investment group Life Science Angels in a seed round to commercialize its high throughput single-cell genomics system. Mission Bio is developing a microfluidic, droplet-based platform to enable critical advances in diseases like cancer, where elucidating heterogeneity in cell populations is essential.

Doctoral Students in Molecular Medicine

Aiming to combine complementary strengths in the Partnership, each institute brings a unique set of expertise, skills, and facilities encompassing the recognized research strengths of the is an international research institute focusing on human genomics and personalised medicine at the Helsinki Institute for Life Science of the University of Helsinki. integrates molecular medicine research and technology centre and biobanking infrastructure under one roof promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine.

Doctoral Students in Molecular Medicine

Aiming to combine complementary strengths in the Partnership, each institute brings a unique set of expertise, skills, and facilities encompassing the recognized research strengths of the is an international research institute focusing on human genomics and personalised medicine at the Helsinki Institute for Life Science of the University of Helsinki. integrates molecular medicine research and technology centre and biobanking infrastructure under one roof promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine.

Innovative Healthcare: Unique Cleveland Clinic is ahead of its time

The multispecialty hospital – Cleveland Clinic Abu Dhabi – has all it needs to deliver high-quality healthcare services to patients visiting the facility not only from the UAE but more than 60 countries but its real success lies in its “patient first” philosophy. Cutting-edge technologies can save lives and cure complicated chronic disease provided that they are supported by relentless, sincere team of qualified physicians.

With mini-vessels, mini-brains expand research potential

IMAGE: Under the microscope, staining highlights a network of vasculature amid the ball of neurons that make up a minibrain. view more PROVIDENCE, R.I. [Brown University] — Scientists have recently made a wondrous variety of mini-brains — 3-D cultures of neural cells that model basic properties of living brains — but a new finding could add to the field’s growing excitement in an entirely new “vein”: Brown University’s mini-brains now grow blood vessels, too.

HEALTH: How Samsung is leveraging VR to manage pain. Together, …

Together, Samsung and AppliedVR are working with a group of hospitals to validate the technology for children and adults. In one randomized controlled trial, the two have collaborated with Cedars-Sinai Medical Center to evaluate the clinical utility of VR for inpatient pain management and its effect on narcotic use, length of stay, and patient satisfaction.

World’s First Stem-Cell Study for Cystic Fibrosis

A 39-year-old man with cystic fibrosis has made history by becoming the first person in the world to receive human adult stem cells in a new study that researchers hope will some day lead to the development of a therapy to reduce the inflammation and infection caused by CF. The study is being conducted at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland, Ohio.

Link between human body clock and breast cancer risk discovered

Biologists in Britain have discovered a link between the human body clock and the risk of breast cancer, the University of Manchester announced Tuesday. Chinese-born Dr. Qing-Jun Meng and Professor Charles Streuli have discovered that breast tissues have 24-hour body clocks, and that several hundred genes are regulated in a daily cycle.

First stem cell study could lead to development of therapy to reduce inflammation caused by CF

A 39-year-old man with cystic fibrosis made history by becoming the first person to receive human adult stem cells in a new research study that researchers hope will someday lead to the development of a therapy to reduce the inflammation and infection caused by CF. The pioneering subject in the study is Bob Held from Alliance, Ohio, who on Jan. 26 received an infusion of cells called allogeneic human mesenchymal stem cells , adult stem cells collected from the bone marrow of healthy volunteers.

Research consortium awarded $21 million NIH grant to find ways to…

An international consortium of academic research institutions have been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy in patients who have suffered traumatic brain injuries. The grant will be led by seven principal investigators at five institutions: Albert Einstein College of Medicine, David Geffen School of Medicine at UCLA, Keck School of Medicine at the University of Southern California, University of Melbourne and University of Eastern Finland.

Surgical robot makes highly precise eye injection possible

For the first time ever, a team of eye surgeons were able to inject a thrombolytic drug directly into a patient’s retinal vein to dissolve a blood clot. It was a success despite the fact that the vein is as thin as human hair thanks to a surgical robot developed by researchers from KU Leuven , a university in Belgium.

Stem cell secretions may protect against glaucoma

A new study in rats shows that stem cell secretions, called exosomes, appear to protect cells in the retina, the light-sensitive tissue in the back of the eye. The findings, published in Stem Cells Translational Medicine , point to potential therapies for glaucoma, a leading cause of blindness in the United States.

Rat-grown mouse pancreases help reverse diabetes in mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Researchers reveal ‘alien’ life using synthetic DNA

Researchers at the Scripps Research Institute in La Jolla, California, introduced DNA molecules not found in nature to a common bacterium The E. coli bugs are able to grow and reproduce as normal despite containing two extra letters in their genetic code In the future the research could lead to creation of microbes capable of manufacturing entirely new proteins that could be used in medicine Some people are worried that the rapid advance of ‘synthetic biology’ could lead to the worrying prospect of new life-forms escaping from labs The modified E.coli bacteria was made by scientists who introduced DNA molecules not found in nature to a common bacterium.